|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Effect of technical parameters on transjugular intrahepatic portosystemic shunts utilizing stent grafts显示文摘AIM: To assess the effect of technical parameters on outcomes of transjugular intrahepatic portosystemic shunt(TIPS) created using a stent graft.METHODS: The medical records of 68 patients who underwent TIPS placement with a stent graft from 2008 to 2014 were reviewed by two radiologists blinded to the patient outcomes.Digital Subtraction Angiographic images with a measuring catheter in two orthogonal planes was used to determine the TIPS stent-to-inferior vena cava distance(SIVCD),hepatic vein to parenchymal tract angle(HVTA),portal vein to parenchymal tract angle(PVTA),and the accessed portal vein.The length and diameter of the TIPS stent and the use of concurrent variceal embolization were recorded by review of the patient's procedure note.Data on re-intervention within 30 d of TIPS placement,recurrence of symptoms,and survival were collected through the patient's chart.Cox proportional regression analysis was performed to assess the effect of these technical parameters on primary patency of TIPS,time to recurrence of symptoms,and all-cause mortality.RESULTS: There was no significant associationbetween the SIVCD and primary patency(P = 0.23),time to recurrence of symptoms(P = 0.83),or allcause mortality(P = 0.18).The 3,6,and 12-mo primary patency rates for a SIVCD ≥ 1.5 cm were 82.4%,64.7%,and 50.3% compared to 89.3%,83.8%,and 60.6% for a SIVCD of < 1.5 cm(P = 0.29).The median time to stenosis for a SIVCD of ≥ 1.5 cm was 19.1 mo vs 15.1 mo for a SIVCD of < 1.5 cm(P = 0.48).There was no significant association between the following factors and primary patency: HVTA(P = 0.99),PVTA(P = 0.65),accessed portal vein(P = 0.35),TIPS stent diameter(P = 0.93),TIPS stent length(P = 0.48),concurrent variceal embolization(P = 0.13) and reinterventions within 30 d(P = 0.24).Furthermore,there was no correlation between these technical parameters and time to recurrence of symptoms or all-cause mortality.Recurrence of symptoms was associated with stent graft stenosis(P = 0.03).CONCLUSION: TIPS stent-to-caval distance and other parameters have no significant effect on primary patency,time to recurrence of symptoms,or all-cause mortality following TIPS with a stent-graft. | Brice Andring Sanjeeva P Kalva Patrick Sutphin Rajiv Srinivasa Alvin Anene Marc Burrell Yin Xi Anil K Pillai | 2015 | World Journal of Gastroenterology2015，21，26： | 7 |
| 2 | Dyspepsia and Irritable Bowel Syndrome After a Salmonella Gastroenteritis Outbreak: One-Year Follow-up Cohort Study显示文摘 | Fermín Mearin Marc Pérez-Oliveras Antonia Perelló Jaume Vinyet Anabel Iba?ez Jordi Coderch Mónica Perona | 2005 | Gastroenterology2005，，1： | 2 |
| 3 | Bovine immunoglobulin protein isolates for the nutritional management of enteropathy显示文摘The gastrointestinal tract is responsible for a multitude of digestive and immune functions which depend upon the balanced interaction of the intestinal microbiota, diet, gut barrier function, and mucosal immune response. Disruptions in one or more of these factors can lead to intestinal disorders or enteropathies which are characterized by intestinal inflammation, increased gut permeability, and reduced capacity to absorb nutrients. Enteropathy is frequently associated with human immunodeficiency virus(HIV) infection, inflammatory bowel disease, autoimmune enteropathy, radiation enteritis, and irritable bowel syndrome(IBS), where pathologic changes in the intestinal tract lead to abdominal discomfort, bloating, abnormal bowel function(e.g., diarrhea, urgency, constipation and malabsorption). Unfortunately, effective therapies for the management ofenteropathy and restoring intestinal health are still not available. An accumulating body of preclinical studies has demonstrated that oral administration of plasmaor serum-derived protein concentrates containing high levels of immunoglobulins can improve weight, normalize gut barrier function, and reduce the severity of enteropathy in animal models. Recent studies in humans, using serum-derived bovine immunoglobulin/protein isolate, demonstrate that such protein preparations are safe and improve symptoms, nutritional status, and various biomarkers associated with enteropathy. Benefits have been shown in patients with HIV infection or diarrhea-predominant IBS. This review summarizes preclinical and clinical studies with plasma/serum protein concentrates and describes the effects on host nutrition, intestinal function, and markers of intestinal inflammation. It supports the concept that immunoglobulin-containing protein preparations may offer a new strategy for restoring functional homeostasis in the intestinal tract of patients with enteropathy. | Bryon W Petschow Anthony T Blikslager Eric M Weaver Joy M Campbell Javier Polo Audrey L Shaw Bruce P Burnett Gerald L Klein J Marc Rhoads | 2014 | World Journal of Gastroenterology2014，20，33： | 2 |
| 4 | Single-Element Solution Comparisons with a High-performance Inductively Coupled Plasma Optical Emission Spectrometry Method显示文摘 | Marc L Salit Gregory C Yurk Abigail P Lindstrom | 2001 | Anal Chem2001，73，： | 2 |
| 5 | Challenges for land system science显示文摘 | Mark D.A. Rounsevell Bas Pedroli Karl-Heinz Erb Marc Gramberger Anne Gravsholt Busck Helmut Haberl S?ren Kristensen Tobias Kuemmerle Sandra Lavorel Marcus Lindner Hermann Lotze-Campen Marc J. Metzger David Murray-Rust Alexander Popp Marta Pérez-Soba Anett | 2012 | Land Use Policy2012，，4： | 2 |
| 6 | Improving the catalytic nitrate reduction 显示文摘 | Ulf P Marc H Jorg D | 2000 | Catalysis Today2000，55，： | 2 |
| 7 | Novel biomarkers for patient stratification in colorectal cancer:A review of definitions,emerging concepts,and data显示文摘Colorectal cancer(CRC) treatment has become more personalised,incorporating a combination of the individual patient risk assessment,gene testing,and chemotherapy with surgery for optimal care.The improvement of staging with high-resolution imaging has allowed more selective treatments,optimising survival outcomes.The next step is to identify biomarkers that can inform clinicians of expected prognosis and offer the most beneficial treatment,while reducing unnecessary morbidity for the patient.The search for biomarkers in CRC has been of significant interest,with questions remaining on their impact and applicability.The study of biomarkers can be broadly divided into metabolic,molecular,micro RNA,epithelial-to-mesenchymal-transition(EMT),and imaging classes.Although numerous molecules have claimed to impact prognosis and treatment,their clinical application has been limited.Furthermore,routine testing of prognostic markers with no demonstrable influence on response to treatment is a questionable practice,as it increases cost and can adversely affect expectations of treatment.In this review we focus on recent developments and emerging biomarkers with potential utility for clinical translation in CRC.We examine and critically appraise novel imaging and molecular-based approaches; evaluate the promising array of micro RNAs,analyze metabolic profiles,and highlight key findings for biomarker potential in the EMT pathway. | Manish Chand Deborah S Keller Reza Mirnezami Marc Bullock Aneel Bhangu Brendan Moran Paris P Tekkis Gina Brown Alex Mirnezami Mariana Berho | 2018 | World Journal of Gastrointestinal Oncology2018，10，7： | 2 |
| 8 | A review of vaccine research and development: human acute respiratory infections显示文摘 | Marc PG Thomas C Yuri P | 2005 | Vaccine2005，23，： | 1 |
| 9 | Spider (Araneae) useful for pest limitation and bioindication 显示文摘 | MARC P CANARD A YSNEL F | 1999 | Agric Ecosyst Environ1999，74，13： | 1 |
| 10 | Bidirectional reflectivity in AVHRR channel 3: Application to a region in northern Africa显示文摘 | Francoise N Francois P and Marc P S | 1998 | Remote Sensing of Environment1998，66，： | 1 |
| 11 | Noise Dressing of Financial Correlation Matrices 显示文摘 | PHILIPPE B MARC P | 1999 | Physical Review Letters1999，83，7： | 1 |
| 12 | Vorapaxar for secondary prevention of thrombotic events for patients with previous myocardial infarction: a prespecified subgroup analysis of the TRA 2°P-TIMI 50 trial显示文摘 | Benjamin M Scirica Marc P Bonaca Eugene Braunwald Gaetano M De Ferrari Daniel Isaza Basil S Lewis Felix Mehrhof Piera A Merlini Sabina A Murphy Marc S Sabatine Michal Tendera Frans Van de Werf Robert Wilcox David A Morrow | 2012 | The Lancet . 2012 (9850)2012，，9850： | 1 |
| 13 | Islet β cell failure in type 2 diabetes显示文摘 | Marc P Christopher J | 2006 | J Clin Invest2006，116，7： | 1 |
| 14 | Early accumulation of PrP(Sc) in gutassociated lymphoid,nervous tissues of suscep-tible sheep from a Romanov flock with natural scrapie显示文摘 | Reoletti O Berthon P Marc D | 2000 | J Gen Virol2000，81，： | 1 |
| 15 | Peritoneal minimal residual disease in colorectal cancer: mechanisms, prevention, and treatment显示文摘 | Wim P Ceelen Marc E Bracke | 2009 | Lancet Oncology2009，，1： | 1 |
| 16 | Effect of ozonation on activated sludge solubilization and mineralization 显示文摘 | DELERIS S P ETIENNE MARC A J MICHEL R | 2000 | Ozone Sci Eng2000，22，： | 1 |
| 17 | Real-time quantitative PCR detection of genetically modified maximizer maize and roundup ready soybean in some representative foods显示文摘 | MARC V HANS P FRANCOIS G | 1999 | J Agric Food Chem1999，47，： | 1 |
| 18 | Near optimum uni- versal belief propagation based decoding of low-density parity check codes显示文摘 | Jinghu Chen Marc P C Fossorier | 2002 | IEEE Trans on Communica tions2002，50，3： | 1 |
| 19 | Low-Density Parity-Check Codes Based on Finite Geometries: a Rediscovery and New Results 显示文摘 | Yu K Shu L Marc P | 2001 | IEEETransactions on Information Theory (S0018-9448)2001，47，7： | 1 |
| 20 | Arc characteristics and behavior of metal transfer in pulsed current GMA welding of aluminum alloy显示文摘 | GHOSH P K DORN L MARC H | 2007 | Journal of Materials Processing Technology2007，194，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员